BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 10820174)

  • 1. Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome.
    Agarwal R; Gorski JC; Sundblad K; Brater DC
    J Am Soc Nephrol; 2000 Jun; 11(6):1100-1105. PubMed ID: 10820174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiloride versus furosemide for the treatment of edema in patients with nephrotic syndrome: A pilot study (AMILOR).
    Schork A; Vogel E; Bohnert BN; Essigke D; Wörn M; Fischer I; Heyne N; Birkenfeld AL; Artunc F
    Acta Physiol (Oxf); 2024 Jun; ():e14183. PubMed ID: 38822593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiazide diuretics are back in CKD: the case of chlorthalidone.
    Minutolo R; De Nicola L; Mallamaci F; Zoccali C
    Clin Kidney J; 2023 Jan; 16(1):41-51. PubMed ID: 36726437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotic Syndrome Complications - New and Old. Part 1.
    Busuioc RM; Mircescu G
    Maedica (Bucur); 2022 Mar; 17(1):153-168. PubMed ID: 35733752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Furosemide and albumin for the treatment of nephrotic edema: a systematic review.
    Hedin E; Bijelić V; Barrowman N; Geier P
    Pediatr Nephrol; 2022 Aug; 37(8):1747-1757. PubMed ID: 35239032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and management of edema in pediatric nephrotic syndrome.
    Kallash M; Mahan JD
    Pediatr Nephrol; 2021 Jul; 36(7):1719-1730. PubMed ID: 33216218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of Diuretic Resistance and Its Implications for the Management of Chronic Heart Failure.
    Wilcox CS; Testani JM; Pitt B
    Hypertension; 2020 Oct; 76(4):1045-1054. PubMed ID: 32829662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loop diuretic resistance complicating acute heart failure.
    Cox ZL; Testani JM
    Heart Fail Rev; 2020 Jan; 25(1):133-145. PubMed ID: 31520280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Furosemide as a functional marker of acute kidney injury in ICU patients: a new role for an old drug.
    Mariano F; Mella A; Vincenti M; Biancone L
    J Nephrol; 2019 Dec; 32(6):883-893. PubMed ID: 31090022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotic Syndrome: Oedema Formation and Its Treatment With Diuretics.
    Gupta S; Pepper RJ; Ashman N; Walsh SB
    Front Physiol; 2018; 9():1868. PubMed ID: 30697163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albuminuria confers renal resistance to loop diuretics via the stimulation of NLRP3 inflammasome/prostaglandin signaling in thick ascending limb.
    Zhuang Y; Jia Z; Hu C; Ding G; Zhang X; Zhang Y; Yang G; Rohatgi R; Huang S; He JC; Zhang A
    Oncotarget; 2017 Sep; 8(44):75808-75821. PubMed ID: 29100270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Disorders of Sodium Balance in Chronic Kidney Disease.
    Ellison DH
    Adv Chronic Kidney Dis; 2017 Sep; 24(5):332-341. PubMed ID: 29031361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diuretic Resistance.
    Hoorn EJ; Ellison DH
    Am J Kidney Dis; 2017 Jan; 69(1):136-142. PubMed ID: 27814935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology, Evaluation, and Management of Edema in Childhood Nephrotic Syndrome.
    Ellis D
    Front Pediatr; 2015; 3():111. PubMed ID: 26793696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications.
    Cadnapaphornchai MA; Tkachenko O; Shchekochikhin D; Schrier RW
    Pediatr Nephrol; 2014 Jul; 29(7):1159-67. PubMed ID: 23989393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of nephrotic syndrome diminishes urinary plasmin content and abolishes activation of ENaC.
    Andersen RF; Buhl KB; Jensen BL; Svenningsen P; Friis UG; Jespersen B; Rittig S
    Pediatr Nephrol; 2013 Aug; 28(8):1227-34. PubMed ID: 23503750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erlotinib preserves renal function and prevents salt retention in doxorubicin treated nephrotic rats.
    Bou Matar RN; Klein JD; Sands JM
    PLoS One; 2013; 8(1):e54738. PubMed ID: 23349960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diuretic use in renal disease.
    Sica DA
    Nat Rev Nephrol; 2011 Dec; 8(2):100-9. PubMed ID: 22183505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications.
    Doucet A; Favre G; Deschênes G
    Pediatr Nephrol; 2007 Dec; 22(12):1983-90. PubMed ID: 17554565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study.
    MacFadyen RJ; Gorski JC; Brater DC; Struthers AD
    Br J Clin Pharmacol; 2004 May; 57(5):622-31. PubMed ID: 15089816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.